Disparities in cardiovascular disease mortality after breast cancer treatment: methodological considerations using real-world data Published December 2021 Citation Calip, GS, Brown-Wade, N, Guadamuz, JS, Wang, X, Miksad, RA, Whitaker, K. . Cancer. . https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.34045 Authors:Calip, GS, Brown-Wade, N, Guadamuz, JS, Wang, X, Miksad, RA, Whitaker, K Sources:Cancer Share Posted inPublicationsHealth equityBreast cancer More publicationsSABCSDecember 2025Racial/ethnic inequities in access to novel therapies and outcomes in triple negative breast cancerMbah O, Ho G, Keane C, Dolor A, Ryals C.Publication summaryPublicationsHealth equityBreast cancerAACR Special Conference in Cancer Research: Artificial Intelligence and Machine LearningJuly 2025Fairness by design: End-to-end bias evaluation for LLM-generated dataEstevez M, Mbah O, Sheikh A, et al.Publication summaryPublicationsData scienceHealth equityBreast cancerArtificial intelligenceASCO Annual MeetingMay 2026Real-world post-progression outcomes following 1L ribociclib + aromatase inhibitor (AI) versus Al alone in African American and low socio-economic status patients with HR+/HER2- mBC in USGadi VK, Hart LL, Tarantino P, et al.Publication summaryPublicationsPrecision medicineHealth equityMetastatic breast cancer